Japan· JP-6131001M2335
アモキシシリン水和物
A amoxicillin product containing アモキシシリン水和物, registered in Japan by 東和薬品, on the national reimbursement list. The same ATC class is registered in 18 of our 19 countries.
Checked against MHLW / PMDA (Japan) on
Informational only — not a medical device.
Where it is registered
Amoxicillin is registered in 18 of 19 countries.
Countries holding a registration under ATC J01CA04 (amoxicillin), each read from that country’s own register.
- This record: Japan, from MHLW / PMDA (Japan)
- 10 of them publish a price we can compare per daily dose
Amoxicillin · ATC J01CA04
18 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of amoxicillin costs, country by country.
Normalised to the WHO defined daily dose (1.5 g), the median price runs from $0.47 in Italy to $2.68 in Switzerland — a ×5.8 gap.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Amoxicillin · price per daily dose (1.5 g)
USD · FX 28 Sept 2026
- CH Switzerland$2.68
- IT Italy$0.47
The record
At a glance
MHLW / PMDA (Japan)- Active substance
- アモキシシリン水和物
- Manufacturer
- 東和薬品
- Country
- Japan (JP)
- ATC code
- J01CA04
- ATC class
- Amoxicillin
- Defined daily dose
- 1.5 g, O
- Reimbursed
- Yes
- Source register
- MHLW / PMDA (Japan)
- Last checked
- September 25, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
321 interactions on record for amoxicillin.
Graded by severity as the source publishes them — 3 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Amoxicillin · interactions on record
321 records
- 3 severe
- 22 moderate
- 7 minor
- 286 info
Most severe, free to view
- MethotrexateL01BA01severe
- MethotrexateL04AX03severe
- MethotrexatM01CX01severe
- Sodium picosulfateA06AB08moderate
3 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under J01CA04
Amoxicillin, as other registers publish it.
- CanadaAG-AMOXICILLINANGITA PHARMA INC.
- CanadaAG-AMOXICILLINANGITA PHARMA INC.
- DenmarkAgeniprimNordic Prime ApS
- DenmarkAgeniprimNordic Prime ApS
- United KingdomAlmodan 125mg/5ml syrupTeva UK Ltd
- United KingdomAmix 125 oral suspensionAshbourne Pharmaceuticals Ltd
- United KingdomAmix 250 capsulesAshbourne Pharmaceuticals Ltd
- United KingdomAmix 250 oral suspensionAshbourne Pharmaceuticals Ltd
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ea5b335e-bb49-4396-b3a0-a74ff17ece1d GET /v1/drugs/ea5b335e-bb49-4396-b3a0-a74ff17ece1d?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"spec": "250mg1カプセル",
"marks": "局",
"source": "mhlw",
"remarks": null,
"yj_code": "6131001M2335",
"category": "内用薬",
"price_yen": 11.2,
"generic_name": "アモキシシリン水和物",
"product_name_jp": null,
"therapeutic_class": "6131",
"transitional_expiry": null
}See everything about amoxicillin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.